<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Aptos;}
@font-face
        {font-family:Cambria;
        panose-1:2 4 5 3 5 4 6 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:#0563C1;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:#954F72;
        text-decoration:underline;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Cambria",serif;
        color:windowtext;}
span.msosmartlink
        {mso-style-name:msosmartlink;
        mso-style-priority:99;
        color:blue;
        background:#F3F2F1;
        text-decoration:underline;}
span.fontsizemedium
        {mso-style-name:fontsizemedium;}
span.apple-converted-space
        {mso-style-name:apple-converted-space;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri",sans-serif;}
@page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
/* List Definitions */
@list l0
        {mso-list-id:79450805;
        mso-list-template-ids:1071312814;}
@list l0:level1
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level2
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:1.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level3
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:1.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level4
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:2.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level5
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:2.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level6
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:3.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level7
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:3.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level8
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:4.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level9
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:4.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
ol
        {margin-bottom:0in;}
ul
        {margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:#212121">Dear EIC Project Team:<span class="apple-converted-space"> </span></span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121"> </span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121">Thank you for participating in the CD-3B/Status Director’s Review Prep Kickoff Meeting last Friday.  If you were not able to attend you can listen to the recording<span class="apple-converted-space"> </span><a href="https://urldefense.com/v3/__https:/bnl.zoomgov.com/rec/share/pHcAGQIL5QSc4npR959SJtjIrQrzDYFelIwEJtcV1v12Q3m95RV8tk2yNJEk5qoi.gcyy988hvaO4p54k?startTime=1725645720000__;!!P4SdNyxKAPE!AtlR_2uK4aLBW_IZ71yNuVK1j6UT3ImhVZ1XoHm_IpGqxdGQaUht2hqkumWCrfHYYIfutdH1Honqno5TqYSzeQ$" title="https://urldefense.com/v3/__https:/bnl.zoomgov.com/rec/share/pHcAGQIL5QSc4npR959SJtjIrQrzDYFelIwEJtcV1v12Q3m95RV8tk2yNJEk5qoi.gcyy988hvaO4p54k?startTime=1725645720000__;!!P4SdNyxKAPE!AtlR_2uK4aLBW_IZ71yNuVK1j6UT3ImhVZ1XoHm_IpGqxdGQaUht2hqkumWCrfHYYIfutdH1"><span style="color:#0078D7">here</span></a>,
 Passcode: d+W30&Yv.  We focused on the goals and key messages for the upcoming review. I want to highlight a few important points to help you prepare your presentations.<span class="apple-converted-space"> </span></span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121"> </span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<b><span style="font-family:"Cambria",serif;color:#212121">Review Goals</span></b><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121">The main purpose of this Director’s review is to help us prepare for the DOE Office of Project Assessment (OPA) CD-3B and Status Review on January 7-9, 2024.  The Director’s Review subcommittees and agenda
 are organized to be like what we expect for the DOE OPA Review.  The DOE committee will evaluate progress on CD-3A Long Lead Procurements, our CD-3B, Long Lead Procurement proposal, and our plans for securing CD-2 and CD-3 in the future.  The subcommittee
 POCs and the speakers should work with their respective subcommittees to ensure that the committee members develop a clear understanding of project status and plans. The information we prepare and share with the committee members should be organized in a manner
 that is easy to navigate. POCs are highly encouraged to contact the SC Chairs before the review.  Our goal is to help the committee perform an effective evaluation of our readiness.  We need a clear understanding of any areas that need improvement prior to
 the January DOE review.<span class="apple-converted-space"> </span></span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121"> </span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<b><span style="font-family:"Cambria",serif;color:#212121">Context for CD-2 Plans<span class="apple-converted-space"> </span></span></b><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<u><span style="font-family:"Cambria",serif;color:#212121">Funding Uncertainty</span></u><span style="font-family:"Cambria",serif;color:#212121">:   We continue to adapt to funding realities, some quite positive, including IRA and NYS, as well as the slower
 than desired ramp-up in our annual EIC appropriation.  DOE provided $390M, including the $138M IRA funding which enabled our CD-3A long-lead procurements.  We also received a $100M grant from New York State for building construction.   Our goal is to deliver
 the EIC facility as efficiently as possible within the DOE annual funding constraints.  We are also motivated to achieve CD-2 in the time frame that RHIC operations concludes at the end of 2025 and to immediately start construction.  Our longer-term plans
 assume DOE peak annual funding of $300M per year.   If history is a guide, we can expect that it will take longer to reach $300M/year than we currently assume and that we will begin FY25 under a Continuing Resolution.  We will present discuss different funding
 scenarios and the implications of these scenarios at the review.   We will also discuss the possibility of delivering the EIC facility in two phases that would enable collisions and early science prior to completion to the full project scope.  These scenarios
 are currently under discussion with our various stakeholders and there is general enthusiasm for plans that enable the delivery of early science as soon as possible.
</span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121"> </span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<u><span style="font-family:"Cambria",serif;color:#212121">Status of CD-3 LLPs and Proposal for CD-3 LLPs:</span></u><span class="apple-converted-space"><span style="font-family:"Cambria",serif;color:#212121"> 
</span></span><span style="font-family:"Cambria",serif;color:#212121">All major updates were frozen in P6 as of September 1.  A proposed CD-3B list was extracted from P6 and posted on our EIC Main SharePoint page.  People responsible for CD-3A and/or CD-B scope
 need to include slides in your presentations specific to 3A and 3B.   The slides model what was presented at the DOE CD-3A review, with CD-3A focusing on status and CD-3B focusing on the proposal.  We are on track with finalizing all related documents.  Cathy
 Lavelle started work on the CD-3B justification form and will be in contact with the people who need to provide more information.<span class="apple-converted-space"> </span></span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121"> </span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<u><span style="font-family:"Cambria",serif;color:#212121">P6:</span></u><span class="apple-converted-space"><span style="font-family:"Cambria",serif;color:#212121"> 
</span></span><span style="font-family:"Cambria",serif;color:#212121">As we prepare to establish the project baseline, we need to address scope not currently included in P6 and to scrub scope already in P6.  There are also important technical decisions pending
 that will be addressed within the next six months and the impact of possible phasing of the facility scope.  The current P6 file is a snapshot capturing where we are today and there is a major effort ahead in 2025 to prepare a P6 file that is consistent with
 the quality needed for a performance baseline and CD-2.   You should be able to describe the scope in your area of responsibility that is in P6 and plans for addressing future updates, e.g., TCCB, CCB Light, CCB, etc..  If your scope will be impacted by potential
 phasing, this can also be identified.  The Dry Runs will be used to ensure messaging is consistent amongst all the speakers on these topics.<span class="apple-converted-space"> </span></span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<b><span style="font-family:"Cambria",serif;color:#212121"> </span></b><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<b><span style="font-family:"Cambria",serif;color:#212121">Prep Schedule</span></b><span style="color:#212121"><o:p></o:p></span></p>
<ul style="margin-top:0in;caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px" type="disc">
<li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Sept 1- All major updates frozen is P6 (Complete)</span><o:p></o:p></span></li><li class="MsoNormal" style="color:#212121;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif;color:#323130">Sept. 6th -Team Prep Kickoff Meeting</span></span><span class="fontsizemedium"><span style="font-family:"Cambria",serif;color:black"> (Complete)</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Sept 13 - Speakers post draft presentation outline on the prep site</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Week of Sept 16 - Page Turns</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Sept 19 - Supporting Document Owners send drafts to Luisella Lari for review</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Sept 24 - Supporting Document Owners post final draft to the prep site</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Sept 27 - Speakers post draft talks to the prep site</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Sept 30 - October 3- Dry Runs</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Oct 7 - Pre-Review Meeting w/ Committee </span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Oct 8 - Site and supporting docs are released to the review team</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Oct 11 - Speakers post final draft talks for QA to the prep site</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Week of October 14 (tentative)-Dress Rehearsals</span></span><o:p></o:p></li><li class="MsoNormal" style="color:#323130;mso-list:l0 level1 lfo1;background:white">
<span class="fontsizemedium"><span style="font-family:"Cambria",serif">Oct 15- Presentations are posted on the review site</span></span><o:p></o:p></li></ul>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<b><span style="font-family:"Cambria",serif;color:#212121"> </span></b><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<b><span style="font-family:"Cambria",serif;color:#212121">Prep site:<span class="apple-converted-space"> </span></span></b><span style="font-family:"Cambria",serif;color:#212121"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__brookhavenlab.sharepoint.com_sites_eRHIC_Prep-5FCD-2D3B&d=DwMFAg&c=CJqEzB1piLOyyvZjb8YUQw&r=d0KG5O9luo0FhuYP-_C2VbpBNln9iudksZOBnX13nypLFx5Y3VKB85tQJ8VLc-jR&m=qCF8m7SyjhuaiWoyJ13Qy_t40nSK2cXcfp7BMeYm8DVPdYOWAGXglCDXTNKEF2mS&s=BL8AUXF24R6Pycjdg-Efvt-bmMXp-vhR3BLtsYoQApU&e=" title="https://brookhavenlab.sharepoint.com/sites/eRHIC/Prep_CD-3B"><span class="msosmartlink">https://brookhavenlab.sharepoint.com/sites/eRHIC/Prep_CD-3B</span></a> <span class="apple-converted-space"> </span></span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<b><span style="font-family:"Cambria",serif;color:#212121"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:#212121">There is a lot of work ahead, but we have done this before and know the routine.  If you have a question, seek out an answer.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#212121"><o:p> </o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121">Sincerely,<span class="apple-converted-space"> </span></span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal" style="caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px">
<span style="font-family:"Cambria",serif;color:#212121">Jim</span><span style="color:#212121"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Aptos"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif"><o:p> </o:p></span></p>
</div>
</body>
</html>